# Illuminant Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/illuminant-surgical

- Industry: Medical Devices & Equipment
- Headquarters: Los Angeles, US
- Website: www.illuminant.ai/
- Total disclosed funding: $8.4M
- Latest round: Seed (Apr 30, 2026)
- Investors on record: 6

## About

Illuminant Surgical, based in the US, specializes in advanced surgical navigation technology, enhancing surgical accuracy through innovative solutions like the Skylight™ system, which projects imaging data directly onto patients' bodies.Illuminant Surgical focuses on developing advanced surgical navigation technology. The company is headquartered in Los Angeles, US. It recently raised USD 8.4 mn in Seed funding led by Wing 2 Wing Foundation, with additional investment from Dorm Room Fund, National Cancer Institute, National Institute on Aging, National Science Foundation, and Soma Capital Management. The total amount raised by the company is USD 8.4 mn, indicating significant investor interest.Illuminant Surgical specializes in advanced surgical navigation technology, with its flagship product being the Skylight™ system. This innovative solution employs real-time anatomical projection for spine surgery and interventional access, projecting imaging data directly onto the patient’s body to enhance surgical accuracy and minimize cognitive load on surgeons. The Skylight™ system utilizes artificial intelligence, computer vision, and dynamic projection mapping to create a seamless integration of digital imaging with physical reality. Targeted primarily at healthcare professionals in surgical settings, core users of this technology include surgeons, interventional radiologists, and pain management specialists across a range of facilities, from university hospitals to private specialty clinics. The company’s products are primarily marketed in North America and Europe, catering to a diverse clientele seeking to improve patient outcomes through enhanced visualization techniques.Illuminant Surgical generates revenue through direct sales and potential partnerships with medical institutions looking to adopt their innovative surgical navigation systems. Transactions typically involve the sale of the Skylight™ system, including associated training and support services, structured as upfront payments for equipment coupled with ongoing service fees. The pricing model may incorporate options for volume discounts for larger healthcare systems or bundled offerings that include training and technical support. Through this transaction structure, the company facilitates the integration of their technology into various healthcare settings, ensuring facilities of all sizes can benefit from advanced surgical navigation capabilities.In April 2026, Illuminant Surgical raised USD 8.4 mn in Seed funding to accelerate the launch of its Skylight platform. The company plans to design and launch new products that enhance their surgical navigation capabilities. Additionally, Illuminant Surgical aims to expand into new geographic markets, particularly in Europe, by the end of 2027. The recent funding will support these initiatives by providing necessary resources for product development and market entry strategies.

## Funding rounds

- Seed, Apr 30, 2026, $8.4M — National Science Foundation, Dorm Room Fund, Soma Capital Management, National Institute on Aging, Wing 2 Wing Foundation, National Cancer Institute

## Investors

- National Science Foundation — Seed
- Dorm Room Fund (https://capitalatlas.ai/funds/dorm-room-fund) — Seed
- Soma Capital Management (https://capitalatlas.ai/funds/soma-capital-management) — Seed
- National Institute on Aging — Seed
- Wing 2 Wing Foundation — Seed
- National Cancer Institute — Seed